Northern Trust’s VanEck Biotech ETF BBH Stock Holding History

Northern Trust’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$300K	Buy	+1,477	New	+$278K	﹤0.01%	3807
2026 Q1	–	Sell	-1,100	Closed	-$208K	–	4410
2025 Q4	$208K	Sell	1,100 -1,020	-48%	-$189K	﹤0.01%	3976
2025 Q3	$351K	Buy	+2,120	New	+$346K	﹤0.01%	3776
2022 Q2	–	Sell	-2,850	Closed	-$462K	–	4750
2022 Q1	$462K	Hold	2,850	–	–	﹤0.01%	3770
2021 Q4	$540K	Sell	2,850 -257	-8%	-$49.6K	﹤0.01%	3779
2021 Q3	$628K	Sell	3,107 -360	-10%	-$75.6K	﹤0.01%	3682
2021 Q2	$699K	Sell	3,467 -187	-5%	-$34.8K	﹤0.01%	3611
2021 Q1	$641K	Buy	3,654 +300	+9%	+$54.2K	﹤0.01%	3743
2020 Q4	$569K	Buy	3,354 +2,053	+158%	+$338K	﹤0.01%	3691
2020 Q3	$211K	Buy	+1,301	New	+$212K	﹤0.01%	3810

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust's BBH Position: Q2 2026 in Review

Northern Trust opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 1,477 shares worth $300K. The stake represents ﹤0.01% of the portfolio and ranks #3807 among its holdings. This is a return to the name: Northern Trust previously reported a position in BBH as recently as Q4 2025.

Northern Trust first reported a position in BBH in Q3 2020 and has held it in 10 quarters since. The position peaked at $699K in Q2 2021. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Northern Trust held 1,477 shares of VanEck Biotech ETF worth $300K as of Q2 2026.
VanEck Biotech ETF was a new Northern Trust position in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3807 holding.
Northern Trust first reported a position in VanEck Biotech ETF in Q3 2020 and has held it in 10 quarters since.
Northern Trust's VanEck Biotech ETF position peaked at $699K in Q2 2021.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.